Viewing Study NCT01719003

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 7:12 PM

Ignite Modification Date: 2026-04-16 @ 3:49 PM

Study NCT ID: NCT01719003

Status: COMPLETED

Last Update Posted: 2016-02-19

First Post: 2012-10-30

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes

Sponsor: Boehringer Ingelheim

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module